Universities, CSIRO and UniSuper-backed seed investment firm Uniseed has taken a stake in medical device company ResusRight.
ResusRight was spun out of development carried out by the University of Sydney and Western Sydney Local Health District. Founded by clinicians and engineers, the company is focused on developing devices for resuscitation at birth.
ResusRight’s first product, the Juno Training Monitor, has been designed to revolutionise training for neonatal resuscitation. The monitor provides real-time objective insight into mask technique, volume delivery and ventilatory rate, used in conjunction with current equipment on neo-natal training manikins. The monitor enables educators to provide targeted feedback to trainees and can be used by clinicians to refresh their skills on their own.
The company is also developing a clinical monitor to assist in resuscitation at birth.
Uniseed has invested $300,000 in ResusRight, alongside existing investors, in a $700,000 SAFE (simple agreement for future equity) round.
Uniseed chief executive Dr Peter Devine said ResusRight’s technology had the potential to transform neonatal resuscitation training.
ResusRight chief executive Matt Boustred said: “We believe our technology has the potential to save lives and should be at every birth. The whole team is very motivated to get it into hospitals where it can begin to help vulnerable babies.”
Uniseed invests in research emanating from its research organisation backers, University of Queensland, University of Sydney, University of NSW, University of Melbourne and CSIRO.
Image: The ResusRight Juno Training Monitor in use.